Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001031447 | SCV001194753 | pathogenic | Hereditary factor IX deficiency disease; Thrombophilia, X-linked, due to factor 9 defect | 2020-12-05 | criteria provided, single submitter | clinical testing | This variant disrupts the C-terminus of the F9 protein. Other variant(s) that disrupt this region (p.Arg294*) have been determined to be pathogenic (PMID: 23093250, 8217825, 10595634, 2270538). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with hemophilia B (PMID: 10739381). This variant is a gross deletion of the genomic region encompassing exon(s) 4-8 of the F9 gene. The 5' boundary is likely confined to intron 3. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. |